These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28988034)

  • 21. Small Molecule Targeting TDP-43's RNA Recognition Motifs Reduces Locomotor Defects in a
    François-Moutal L; Felemban R; Scott DD; Sayegh MR; Miranda VG; Perez-Miller S; Khanna R; Gokhale V; Zarnescu DC; Khanna M
    ACS Chem Biol; 2019 Sep; 14(9):2006-2013. PubMed ID: 31241884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid-Liquid Phase Separation Enhances TDP-43 LCD Aggregation but Delays Seeded Aggregation.
    Pakravan D; Michiels E; Bratek-Skicki A; De Decker M; Van Lindt J; Alsteens D; Derclaye S; Van Damme P; Schymkowitz J; Rousseau F; Tompa P; Van Den Bosch L
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33917983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A complex network of interdomain interactions underlies the conformational ensemble of monomeric TDP-43 and modulates its phase behavior.
    Mohanty P; Rizuan A; Kim YC; Fawzi NL; Mittal J
    Protein Sci; 2024 Feb; 33(2):e4891. PubMed ID: 38160320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase to Phase with TDP-43.
    Sun Y; Chakrabartty A
    Biochemistry; 2017 Feb; 56(6):809-823. PubMed ID: 28112502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis.
    Pakravan D; Orlando G; Bercier V; Van Den Bosch L
    J Mol Cell Biol; 2021 Apr; 13(1):15-28. PubMed ID: 32976566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALS-causing cleavages of TDP-43 abolish its RRM2 structure and unlock CTD for enhanced aggregation and toxicity.
    Wei Y; Lim L; Wang L; Song J
    Biochem Biophys Res Commun; 2017 Apr; 485(4):826-831. PubMed ID: 28257838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A synergy between site-specific and transient interactions drives the phase separation of a disordered, low-complexity domain.
    Mohanty P; Shenoy J; Rizuan A; Mercado-Ortiz JF; Fawzi NL; Mittal J
    Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2305625120. PubMed ID: 37579155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter-domain interactions of TDP-43 as decoded by NMR.
    Wei Y; Lim L; Wang L; Song J
    Biochem Biophys Res Commun; 2016 Apr; 473(2):614-9. PubMed ID: 27040765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain.
    Haider R; Shipley B; Surewicz K; Hinczewski M; Surewicz WK
    bioRxiv; 2024 Mar; ():. PubMed ID: 38585945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aromatic and aliphatic residues of the disordered region of TDP-43 are on a fast track for self-assembly.
    Laurents DV; Stuani C; Pantoja-Uceda D; Buratti E; Mompeán M
    Biochem Biophys Res Commun; 2021 Nov; 578():110-114. PubMed ID: 34560580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between the Intrinsically Disordered Regions of hnRNP-A2 and TDP-43 Accelerate TDP-43's Conformational Transition.
    Chiang WC; Lee MH; Chen TC; Huang JR
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of TDP-43 in the pathogenesis of ALS and FTLD.
    Baralle M; Buratti E; Baralle FE
    Biochem Soc Trans; 2013 Dec; 41(6):1536-40. PubMed ID: 24256250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific RNA interactions promote TDP-43 multivalent phase separation and maintain liquid properties.
    Grese ZR; Bastos AC; Mamede LD; French RL; Miller TM; Ayala YM
    EMBO Rep; 2021 Dec; 22(12):e53632. PubMed ID: 34787357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FTLD/ALS-linked TDP-43 mutations do not alter TDP-43's ability to self-regulate its expression in Drosophila.
    Miguel L; Avequin T; Pons M; Frebourg T; Campion D; Lecourtois M
    Brain Res; 2018 Sep; 1695():1-9. PubMed ID: 29778779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of chemically oligomerizable TAR DNA-binding protein-43 which mimics amyotrophic lateral sclerosis pathology in mammalian cells.
    Yamanaka Y; Miyagi T; Harada Y; Kuroda M; Kanekura K
    Lab Invest; 2021 Oct; 101(10):1331-1340. PubMed ID: 34131277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biophysical Studies of LLPS and Aggregation of TDP-43 LCD.
    Babinchak WM; Surewicz WK
    Methods Mol Biol; 2023; 2551():497-513. PubMed ID: 36310222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALS-causing D169G mutation disrupts the ATP-binding capacity of TDP-43 RRM1 domain.
    Dang M; Song J
    Biochem Biophys Res Commun; 2020 Apr; 524(2):459-464. PubMed ID: 32007267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ADP-ribose) Engages the TDP-43 Nuclear-Localization Sequence to Regulate Granulo-Filamentous Aggregation.
    McGurk L; Gomes E; Guo L; Shorter J; Bonini NM
    Biochemistry; 2018 Dec; 57(51):6923-6926. PubMed ID: 30540446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The N-Terminal Domain of ALS-Linked TDP-43 Assembles without Misfolding.
    Tsoi PS; Choi KJ; Leonard PG; Sizovs A; Moosa MM; MacKenzie KR; Ferreon JC; Ferreon ACM
    Angew Chem Int Ed Engl; 2017 Oct; 56(41):12590-12593. PubMed ID: 28833982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.